» Articles » PMID: 9863527

Hydroxyapatite Fiber Reinforced Poly(alpha-hydroxy Ester) Foams for Bone Regeneration

Overview
Journal Biomaterials
Date 1998 Dec 24
PMID 9863527
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

A process has been developed to manufacture biodegradable composite foams of poly(DL-lactic-co-glycolic acid) (PLGA) and hydroxyapatite short fibers for use in bone regeneration. The processing technique allows the manufacture of three-dimensional foam scaffolds and involves the formation of a composite material consisting of a porogen material (either gelatin microspheres or salt particles) and hydroxyapatite short fibers embedded in a PLGA matrix. After the porogen is leached out, an open-cell composite foam remains which has a pore size and morphology defined by the porogen. By changing the weight fraction of the leachable component it was possible to produce composite foams with controlled porosities ranging from 0.47 +/- 0.02 to 0.85 +/- 0.01 (n = 3). Up to a polymer:fiber ratio of 7:6, short hydroxyapatite fibers served to reinforce low-porosity PLGA foams manufactured using gelatin microspheres as a porogen. Foams with a compressive yield strength up to 2.82 +/- 0.63 MPa (n = 3) and a porosity of 0.47 +/- 0.02 (n = 3) were manufactured using a polymer:fiber weight ratio of 7:6. In contrast, high-porosity composite foams (up to 0.81 +/- 0.02, n = 3) suitable for cell seeding were not reinforced by the introduction of increasing quantities of hydroxyapatite short fibers. We were therefore able to manufacture high-porosity foams which may be seeded with cells but which have minimal compressive yield strength, or low porosity foams with enhanced osteoconductivity and compressive yield strength.

Citing Articles

Horizon of exosome-mediated bone tissue regeneration: The all-rounder role in biomaterial engineering.

Wang W, Liang X, Zheng K, Ge G, Chen X, Xu Y Mater Today Bio. 2022; 16:100355.

PMID: 35875196 PMC: 9304878. DOI: 10.1016/j.mtbio.2022.100355.


Recent advances and future perspectives of sol-gel derived porous bioactive glasses: a review.

Deshmukh K, Kovarik T, Krenek T, Docheva D, Stich T, Pola J RSC Adv. 2022; 10(56):33782-33835.

PMID: 35519068 PMC: 9056785. DOI: 10.1039/d0ra04287k.


Sustained delivery of PlGF-2-fused BMP2-related peptide P28 from small intestinal submucosa/polylactic acid scaffold material for bone tissue regeneration.

Xiong Z, Cui W, Sun T, Teng Y, Qu Y, Yang L RSC Adv. 2022; 10(12):7289-7300.

PMID: 35493905 PMC: 9049782. DOI: 10.1039/c9ra07868a.


Biological evaluation of the modified nano-amorphous phosphate calcium doped with citrate/poly-amino acid composite as a potential candidate for bone repair and reconstruction.

Wang X, Zhao D, Ren H, Yan Y, Li S J Mater Sci Mater Med. 2021; 32(1):16.

PMID: 33491099 PMC: 7829244. DOI: 10.1007/s10856-020-06482-7.


Preparation, Characterization and In Vitro Biological Evaluation of a Novel Pearl Powder/Poly-Amino Acid Composite as a Potential Substitute for Bone Repair and Reconstruction.

Wu Y, Ding Z, Ren H, Ji M, Yan Y Polymers (Basel). 2019; 11(5).

PMID: 31071963 PMC: 6572604. DOI: 10.3390/polym11050831.